CFI-400945 is an oral PLK-4 inhibitor that is being studied for use in several different cancers.
| SparkCures ID | 589 |
|---|---|
| Generic Name | CFI-400945 |
| Treatment Classifications |
|
There are no resources, links or videos to display for this treatment.